Company / SG&A per Share
Perspective Therapeutics, Inc. SG&A per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.04
FY2022
5-year range
$0.04 / $0.07
FY2018-FY2022
Trend
-35.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 3 consecutive years, from $0.07 in FY2019 to $0.04 in FY2022.
Based on SEC 10-K filings.
0.04 in FY2022 with a 5-year CAGR of -2.1%.
Improved from $0.06 to $0.04 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -17.4%
- 5-Year CAGR
- -2.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Perspective Therapeutics, Inc.'s sg&a per share has declined for 3 consecutive years.
- In FY2022, sg&a per share decreased 35.2% year-over-year.
- Peak sg&a per share was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.04 | -35.2% |
| FY2021 | $0.06 | -2.0% |
| FY2020 | $0.06 | -11.2% |
| FY2019 | $0.07 | +1.1% |
| FY2018 | $0.07 | +57.7% |
| FY2017 | $0.04 | -27.1% |
| FY2016 | $0.06 | +8.5% |
| FY2015 | $0.06 | -16.7% |
| FY2014 | $0.07 | -12.9% |
| FY2013 | $0.08 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026